Assenagon Asset Management S.A.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in ALNY
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$46,868,865
+$4,221,046 QoQ
Shares Held
155,695
+20.8% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#89
of 784 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. ALNY ranks #11 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in ALNY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,868,865 | 155,695 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $42,647,819 | 128,896 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $10,175,863 | 25,590 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $36,653,736 | 80,381 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $5,767,227 | 17,686 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,729,478 | 6,405 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $4,686,904 | 19,918 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $4,849,603 | 17,633 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $29,839,428 | 122,796 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $9,018,111 | 60,342 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $2,711,514 | 14,166 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,191,883 | 6,730 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $17,258,328 | 90,862 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $43,107,061 | 215,191 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,860,086 | 7,827 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,252,601 | 6,258 | Shares | Sole | 2022-10-27 | |
| 2021-12-31 | $29,582,043 | 174,443 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $63,117,106 | 334,289 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $48,109,776 | 283,800 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $17,474,803 | 123,768 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,941,611 | 22,633 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $6,287,736 | 43,185 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $17,553,849 | 118,519 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $2,602,821 | 23,912 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||